Fundamental Valuation Report RH(RH:NYS) Consumer Cyclical:Specialty Retail This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$699.05 (USD) 05/03/2021 Weighted Valuation$350.78 (USD) Overall RatingOvervalued by 49.8% Valuation Models Comparables: $205.69 (USD) (in …
RH (RH:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Veeva Systems(VEEV:NYS) Healthcare:Health Information Services This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$277.76 (USD) 05/03/2021 Weighted Valuation$283.48 (USD) Overall RatingFairly valued to slightly Undervalued by 2.1% Valuation …
Veeva Systems (VEEV:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Dell Technologies(DELL:NYS) Technology:Computer Hardware This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$97.78 (USD) 05/03/2021 Weighted Valuation$99.23 (USD) Overall RatingFairly valued to slightly Undervalued by 1.5% Valuation Models …
Dell Technologies (DELL:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Cloudera(CLDR:NYS) Technology:Software – Application This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$12.37 (USD) 05/03/2021 Weighted Valuation$14.71 (USD) Overall RatingUndervalued by 19.0% Valuation Models Comparables: $14.42 (USD) Adjusted …
Cloudera (CLDR:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Foot Locker(FL:NYS) Consumer Cyclical:Footwear & Accessories This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$61.41 (USD) 05/03/2021 Weighted Valuation$59.30 (USD) Overall RatingFairly valued to slightly Overvalued by 3.4% …
Foot Locker (FL:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report GameStop(GME:NYS) Consumer Cyclical:Specialty Retail This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$162.20 (USD) 05/03/2021 Weighted Valuation$83.48 (USD) Overall RatingOvervalued by 48.5% Valuation Models Comparables: $83.48 (USD) Valuation …
GameStop (GME:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Ambarella(AMBA:NAS) Technology:Semiconductor Equipment & Materials This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$94.31 (USD) 05/03/2021 Weighted Valuation$97.73 (USD) Overall RatingFairly valued to slightly Undervalued by 3.6% Valuation …
Ambarella (AMBA:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Innergex Renewable Energy(INE:TSE) Utilities:Utilities – Renewable This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$21.00 (CAD) 04/30/2021 Weighted Valuation$24.19 (CAD) Overall RatingUndervalued by 15.2% Valuation Models Adjusted …
Innergex Renewable Energy (INE:TSE) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Insmed(INSM:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$33.73 (USD) 04/30/2021 Weighted Valuation$31.94 (USD) Overall RatingOvervalued by 5.3% Valuation Models Comparables: $24.58 (USD) (in order of …
Insmed (INSM:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Iovance Biotherapeutics(IOVA:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$31.44 (USD) 04/30/2021 Weighted Valuation$28.57 (USD) Overall RatingOvervalued by 9.1% Valuation Models Comparables: $26.70 (USD) (in order …
Iovance Biotherapeutics (IOVA:NAS) Fundamental Valuation Report Read more »
Read More